Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Phenylephrine 1000 mcg in 0.9% Sodium Chloride 10 mL

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Terminated Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0144-2018
Class II · Moderate risk

Oxytocin 30 units in 0.9% Sodium Chloride 500 mL

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Terminated Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0143-2018
Class II · Moderate risk

Norepinephrine 8 mg in dextrose 5% 250 mL

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Terminated Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0142-2018
Class II · Moderate risk

Neostigmine Methylsulfate 5 mg/5 mL

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Terminated Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0141-2018
Class II · Moderate risk

Morphine 50 mg in 0.9% Sodium Chloride 5 mL PCA

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Terminated Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0140-2018
Class II · Moderate risk

HYDROmorphone 10 mg in 0.9% Sodium Chloride 50 mL PCA

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Terminated Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0139-2018
Class II · Moderate risk

Amiodarone 900 mg in dextrose 5% 500 mL

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Terminated Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0137-2018
Class II · Moderate risk

Fentanyl 10 mcg in 0.9% Sodium Chloride 1 mL

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Terminated Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0136-2018
Class II · Moderate risk

Neostigmine Methylsulfate

Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.

Terminated Stability / shelf life Premier Pharmacy Labs Inc NDC 69623-234-15 D-0129-2018
Class I · High risk

Pravastatin Sodium Tablets

Labeling: Label mix-up, the product labeled as Pravastatin sodium tablets 40 mg was filled with Bupropion hydrochloride XL Tablets 300 mg.

Terminated Labeling / mix-up International Laboratories, Inc. NDC 54458-925-16 D-0102-2018
Class II · Moderate risk

Povidone Iodine

Labeling: Label mix-up. Finished product Povidone iodine 7.5% was labeled as Povidone iodine 10% , the outer box had the correct label.

Terminated Labeling / mix-up Degasa Sa De Cv NDC 68345-350-09 D-1129-2017
Class II · Moderate risk

Vitamin A&D Ointment

Labeling Mixup; the individual A&D ointment foil packets are incorrectly labeled as petroleum jelly. The boxes and outer case are correctly labeled as A&D ointment.

Terminated Labeling / mix-up Medline Industries INC D-1138-2017
Class III · Low risk

Phentermine HCL Capsules

Failed Impurities/Degradation Specifications: out-of-specification results obtained for individual unknown impurities found at 30 month Room Temperature Retained Sample stability test.

Terminated Impurity / degradation KVK-Tech, Inc. NDC 10702-026-01 D-1083-2017
Class I · High risk

Lorazepam Oral Concentrate

Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.

Terminated Packaging defect Amneal Pharmaceuticals of New York, LLC NDC 65162-687-84 D-0120-2018
Class II · Moderate risk

Rugby Aller-chlor

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1122-2017
Class II · Moderate risk

Rugby Diocto Syrup

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1120-2017
Class II · Moderate risk

Rugby Diocto Liquid

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1119-2017
Class I · High risk

Natural Herbal Coffee Ampt

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil and tadalafil and undeclared milk. The presence of sildenafil and tadalafil makes AMPT Natural Herbal Coffee an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. Additionally, this product has been found to contain undeclared milk, milk is recognized as one of the foods reported to have caused deaths due to anaphylactic shock in persons with underlying hypersensitivities.

Terminated Chemical / undeclared The Ampt Life, LLC D-0126-2018

Recalls by year